Foghorn Therapeuticsinc Stock Target Price

FHTX Stock  USD 5.99  0.12  1.96%   
Foghorn TherapeuticsInc fundamentals help investors to digest information that contributes to Foghorn TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Foghorn Stock. The fundamental analysis module provides a way to measure Foghorn TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Foghorn TherapeuticsInc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Foghorn TherapeuticsInc Current Valuation Drivers

We derive many important indicators used in calculating different scores of Foghorn TherapeuticsInc from analyzing Foghorn TherapeuticsInc's financial statements. These drivers represent accounts that assess Foghorn TherapeuticsInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Foghorn TherapeuticsInc's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap667.2M745.8M850.1M265.4M270.7M257.2M
Enterprise Value668.8M735.0M807.3M(28.9M)235.5M223.7M

Foghorn Fundamentals

About Foghorn TherapeuticsInc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Foghorn TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Foghorn TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Foghorn TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Foghorn TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Foghorn TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Foghorn Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Foghorn Therapeuticsinc Stock:
Check out Foghorn TherapeuticsInc Piotroski F Score and Foghorn TherapeuticsInc Altman Z Score analysis.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Foghorn Stock analysis

When running Foghorn TherapeuticsInc's price analysis, check to measure Foghorn TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn TherapeuticsInc is operating at the current time. Most of Foghorn TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Foghorn TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn TherapeuticsInc's price. Additionally, you may evaluate how the addition of Foghorn TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Foghorn TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Foghorn TherapeuticsInc. If investors know Foghorn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Foghorn TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.34)
Revenue Per Share
0.814
Quarterly Revenue Growth
0.379
Return On Assets
(0.20)
Return On Equity
(4.70)
The market value of Foghorn TherapeuticsInc is measured differently than its book value, which is the value of Foghorn that is recorded on the company's balance sheet. Investors also form their own opinion of Foghorn TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Foghorn TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Foghorn TherapeuticsInc's market value can be influenced by many factors that don't directly affect Foghorn TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Foghorn TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Foghorn TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foghorn TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.